Basics Arcellx, Inc. Common Stock IPO Date: February 4, 2022 Sector: Healthcare Industry: Biotech Market Cap: $3.41B Activated in VL: True Average Daily Range Avg Daily Range: $1.15 | 2.83% Avg Daily Range (30 D): $1.54 | 2.51% Avg Daily Range (90 D): $1.78 | 2.83% Institutional Daily Volume Avg Daily Volume: .42M Avg Daily Volume (30 D): .73M Avg Daily Volume (90 D): .59M Trade Size Avg Trade Size (Sh.): 53 Avg Trade Size (Sh.) (30 D): 53 Avg Trade Size (Sh.) (90 D): 49 Institutional Trades Total Inst.Trades: 1,818 Avg Inst. Trade: $2.53M Avg Inst. Trade (30 D): $2.74M Avg Inst. Trade (90 D): $2.99M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.98M Avg Closing Trade (30 D): $5.8M Avg Closing Trade (90 D): $5.63M Avg Closing Volume: 80.74K     News May 23, 2025 @ 1:10 PM New Data and Deal Flow Signal a Turning Point for ... Source: Prnewswire May 12, 2025 @ 5:00 PM Blood Cancer Treatment Market Sees Accelerated Gro... Source: Delveinsight Mar 5, 2025 @ 6:00 PM CAR T-cell Therapy Clinical Trial Pipeline Experie... Source: Delveinsight Feb 12, 2025 @ 8:22 PM Gilead Ups 2025 Outlook, Eyes Lenacapavir Launch F... Source: Vandana Singh May 31, 2024 @ 12:01 PM Expert Ratings For Arcellx Source: Benzinga Insights Financials   TTM Q1 2025 Q3 2024 Basic EPS $-1.13 $-.48 Diluted EPS $-1.13 $-.48 Revenue $ $ 8.13M $ 26.03M Gross Profit $ $ $ Net Income / Loss $ $ -62.27M $ -25.87M Operating Income / Loss $ $ -68.9M $ -33.62M Cost of Revenue $ $ $ Net Cash Flow $ $ -24.82M $ 61.82M PE Ratio